Photon Therapy Versus Proton Therapy in Early Tonsil Cancer. — ARTSCAN V

Tonsil Cancer Clinical Trial

Official title:
Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

Status Recruiting

Clinical Trial Summary

In this trial, patients with early squamous cell carcinoma of the tonsil with clinical stage T1-2 (p16-positive or p16-negative) N0-1 (p16-positive)/N0-N2b (p16-negative) according to American Joint Committee on Cancer (AJCC) 8th edition, aimed for unimodal and ipsilateral treatment with radiotherapy with curative intent will be included. The patients will be randomized to in a 1:1 ratio to receive radiotherapy with either photons (conventional radiotherapy) versus radiotherapy with protons.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Tonsil Cancer

Clinical Trial Details

NCT number	NCT03829033
Study type	Interventional
Source	Lund University Hospital
Contact	Maria Gebre-Medhin, MD
Phone	+46 46 17 75 20
Email	maria.gebre-medhin@skane.se
Status	Recruiting
Phase	N/A
Start date	January 22, 2019
Completion date	January 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05698667` - Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer	N/A
Completed	`NCT03602079` - Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	Phase 1/Phase 2
Recruiting	`NCT05696314` - Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx	N/A
Completed	`NCT03226613` - New Modalities for Detection of Oropharyngeal Cancer	N/A
Recruiting	`NCT04277858` - Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.	Phase 2